Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Investigate how wide market index funds compare to the SP 500 for retirement planning, highlighting diversification and expense considerations.
28,387 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
In May, sweetgreen stock jumped 45% as the company signaled a path to recovery. This article breaks down the catalyst...
With SpaceX poised to hit the public markets, a wave of megadeals led by Elon Musk looms. Analysts warn the IPO could...
Bitcoin slides to $58K as risk-off sentiment expands across digital assets, erasing roughly $120B in market value and...
Marvell Technology tumbles on revised AI capex forecasts, intensifying a wider retreat in semiconductor names. Major ...
A major institutional move is shaping Balchem's next chapter. As the company posts record sales, a new investor stake...
Rivian’s April milestone could reshape its growth path. This article breaks down why April could huge for Rivian, wha...
A practical, plain‑language breakdown of Navigator NVGS's Q1 2026 earnings trajectory. Learn what drives revenue, how...
From classroom grades to a billion-dollar chicken brand, Raising Cane’s growth highlights the power—and perils—of a s...
Hewlett Packard Enterprise beats expectations, pulling forward its 2028 targets by two years as AI infrastructure dem...
A surprising rally in small-cap value equities challenges the usual price-pressures from inflation and higher rates. ...
GCC debt markets climbed again this week, with six new issues totaling about $6.8 billion and spreads tightening as i...